Andrew Tatham, MD, MBA, FRCOphth, FEBO, outlines the role of micro-invasive glaucoma surgery alongside established glaucoma ...
AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.
At the 2nd International Glaucoma Symposium in Mainz, Germany, on 31 January 2026, optical coherence tomography (OCT) and its role in glaucoma and neuro-ophthalmic disease took centre stage in a ...
The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...
Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...
To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod ...
Schulz: When shaping the International Glaucoma Symposium 2026 agenda, we intentionally built a balanced program that reflects both core clinical practice and the rapid evolution of technology in ...
The study highlights the importance of shear-thinning behavior in artificial tears, crucial for mimicking natural tear ...
Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results